افتح القائمة الرئيسية

تغييرات

ط
بوت:إضافة قالب تصفح {{كوليرا}}
| للوقاية من العدوى عند المصابين ب[[فيروس العوز المناعي البشري]] || {{No}} || {{No}} || {{No}} || <ref>{{cite journal |title=Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda |journal=The Lancet |volume=364 |issue=9443 |date=October 2004 |pages=1428–1434 |doi=10.1016/S0140-6736(04)17225-5 |pmid=15488218 |author=Mermin, J; Lule, J; Ekwaru, JP; Malamba, S; Downing, R; Ransom, R; Kaharuza, F; Culver, D; Kizito, F; Bunnell, R; Kigozi, A; Nakanjako, D; Wafula, W; Quick, R}}</ref>
|-
| [[التهاب الأذن الوسطى]] || {{Yes|<small>للأطفال فقط</small>}} || {{No}} || {{Yes}} || <ref>{{cite journal |title=Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media: a randomized, placebo-controlled trial |journal=Pediatrics |date=May 2007 |volume=119 |issue=5 |pages=897–904 |doi=10.1542/peds.2006-2787 |pmid=17473089 |author=van der Veen, EL; Rovers, MM; Albers, FW; Sanders, EA; Schilder, AG |url=http://pediatrics.aappublications.org/content/119/5/897.full.pdf |format=PDF }}</ref><ref>{{cite journal |title=Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media |journal=Pediatric Infectious Disease Journal |date=March 2001 |volume=20 |issue=3 |pages=260–264 |doi=10.1097/00006454-200103000-00009 |pmid=11303827 |author=Leiberman, A; Leibovitz, E; Piglansky, L; Raiz, S; Press, J; Yagupsky, P; Dagan, R}}</ref>
|-
| للوقاية من [[إسهال المسافرين]] وعلاجه || {{Yes}} || {{No}} || {{No}} || <ref>{{cite journal |title=Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial |journal=Annals of Internal Medicine |volume=106 |issue=2 |pages=216–220 |date=February 1987 |doi=10.7326/0003-4819-106-2-216 |pmid=3541724 |author=Ericsson, CD; Johnson, PC; Dupont, HL, Morgan DR, Bitsura JA, de la Cabada FJ}}</ref><ref>{{cite journal |title=Treatment of traveler's diarrhea with sulfamethoxazole and trimethoprim and loperamide |journal=Journal of the American Medical Association |date=January 1990 |volume=263 |issue=2 |pages=257–261 |doi=10.1001/jama.1990.03440020091039 |pmid=2403603 |author=Ericsson, CD; DuPont, HL; Mathewson, JJ; West, MS; Johnson, PC; Bitsura, JA}}</ref><ref>{{cite journal |title=Drug Prophylaxis for Travelers' Diarrhea |journal=Clinical Infectious Diseases |date=March 2002 |volume=34 |issue=5 |pages=628–633 |doi=10.1086/338640 |pmid=11803509 |author=Rendi-Wagner, P; Kollaritsch, H |url=http://cid.oxfordjournals.org/content/34/5/628.full.pdf |format=PDF }}</ref>
|-
| [[عدوى الجهاز البولي]] || {{Yes}} || {{No}} || {{Yes}} || <ref name="Drugs">{{cite journal |title=Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy |journal=Drugs |volume=24 |issue=6 |pages=459–518 |date=December 1982 |doi=10.2165/00003495-198224060-00002 |pmid=6759092 |author=Wormser, GP; Keusch, GT; Heel, RC}}</ref>
| [[لستيريا]] || {{No}} || {{Yes}} || {{No}} || .
|-
| [[راعوم]] || {{No}} || {{Yes}} || {{No}} || <ref>{{cite journal |title=Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline |journal=The American Journal of Tropical Medicine and Hygiene |date=January 2001 |volume=64 |issue=1-2 |pages=24–27 |pmid=11425157 |format=PDF |url=http://www.ajtmh.org/content/64/1/24.full.pdf |author=Chetchotisakd, P; Chaowagul, W; Mootsikapun, P; Budhsarawong, D; Thinkamrop, B}}</ref><ref>{{cite journal |title=Outcomes of patients with melioidosis treated with cotrimoxazole alone for eradication therapy |journal=The American Journal of Tropical Medicine and Hygiene |date=November 2012 |volume=87 |issue=5 |pages=927–932 |doi=10.4269/ajtmh.2012.12-0136 |pmid=23033403 |pmc=3516270 |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516270/pdf/tropmed-87-927.pdf |format=PDF }}</ref><ref>{{cite journal |title=Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial |journal=The Lancet |date=November 2013 |doi=10.1016/S0140-6736(13)61951-0 |pmid=24284287 |author=Chetchotisakd, P; Chierakul, W; Chaowagul, W; Anunnatsiri, S; Phimda, K; Mootsikapun, P; Chaisuksant, S; Pilaikul, J; Thinkhamrop, B; Phiphitaporn, S; Susaengrat, W; Toondee, C; Wongrattanacheewin, S; Wuthiekanun, V; Chantratita, N; Thaipadungpanit, J; Day, NP; Limmathurotsakul, D; Peacock, SJ |pmc=3939931 |volume=383 |issue=9919 |pages=807–14}}</ref>
|-
| [[السعال الديكي]] || {{No}} || {{No}} || {{No}} || <ref>{{cite journal |title=Antibiotics for whooping cough (pertussis) |journal=The Cochrane Database of Systematic Reviews |issue=3 |pages=CD004404 |date=July 2007 |doi=10.1002/14651858.CD004404.pub2 |pmid=15674946 |url=http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004404.pub3/pdf |author=Altunaiji, S; Kukuruzovic, R; Curtis, N; Massie, J}}</ref>
| [[زحار]] || {{Yes}} || {{Yes}} || {{No}} || <ref>{{cite web |title=''Shigella'' Infection Medication |work=Medscape Reference |publisher=WebMD |date=25 June 2012|accessdate=8 January 2014 |url=http://emedicine.medscape.com/article/968773-medication#showall |author=Sureshbabu, J; Venugopalan, P; Abuhammour, W|editor=Fennelly, G; Windle, ML; Lutwick, LI; Tolan Jr, RW; Steele, RW}}</ref><ref>{{cite journal |title=Antibiotic therapy for ''Shigella'' dysentery (Review) |journal=The Cochrane Database of Systematic Reviews |date=August 2010 |issue=8 |doi=10.1002/14651858.CD006784.pub4 |url=http://www.thecochranelibrary.com/userfiles/ccoch/file/Water%20safety/CD006784.pdf |format=PDF |pages=CD006784 |author=Christopher, PR; David, KV; John, SM; Sankarapandian, V |pmid=20687081}}</ref>
|-
| عدوى [[المكورات العنقودية الذهبية]] || {{No}} || {{No}} || {{No}} || <ref>{{cite journal |title=Trimethoprim-Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin-Resistant ''Staphylococcus aureus'' |journal=Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy |date=February 2005 |volume=25 |issue=2 |pages=253–264 |doi=10.1592/phco.25.2.253.56956 |pmid=15767239 |author=Grim, SA; Rapp, RP; Martin, CA; Evans, ME}}</ref><ref>{{cite journal |title=Prospective Randomized Trial of Empiric Therapy with Trimethoprim-Sulfamethoxazole or Doxycycline for Outpatient Skin and Soft Tissue Infections in an Area of High Prevalence of Methicillin-Resistant ''Staphylococcus aureus'' |journal=Antimicrobial Agents and Chemotherapy |date=July 2007 |volume=51 |issue=7 |pages=2628–2630 |doi=10.1128/AAC.00206-07 |pmid=17502411 |pmc=1913240 |author=Cenizal, MJ; Skiest, D; Luber, S; Bedimo, R; Davis, P; Fox, P; Delaney, K; Hardy, RD |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913240/pdf/0206-07.pdf |format=PDF }}</ref><ref>{{cite journal |title=Activities of Clindamycin, Daptomycin, Doxycycline, Linezolid, Trimethoprim-Sulfamethoxazole, and Vancomycin against Community-Associated Methicillin-Resistant ''Staphylococcus aureus'' with Inducible Clindamycin Resistance in Murine Thigh Infection and In Vitro Pharmacodynamic Models |journal=Antimicrobial Agents and Chemotherapy |date=April 2008 |volume=52 |issue=6 |pages=2156–2162 |doi=10.1128/AAC.01046-07 |pmid=18411321 |pmc=2415789 |author=LaPlante, KL; Leonard, SN; Andes, DR; Craig, WA; Rybak, MJ |url=http://aac.asm.org/content/52/6/2156.full.pdf |format=PDF }}</ref><ref>{{cite journal |title=Trimethoprim-sulfamethoxazole for methicillin-resistant ''Staphylococcus aureus'': a forgotten alternative? |journal=Journal of Chemotherapy |volume=21 |issue=2 |pages=115–126 |date=April 2009 |author=Pappas, G; Athanasoulia, AP; Matthaiou, DK; Falagas, ME|issn=1973-9478 |pmid=19423463 |doi=10.1179/joc.2009.21.2.115}}</ref><ref>{{cite journal |title=Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant ''Staphylococcus aureus'' bacteraemia: A retrospective cohort study |journal=Journal of Antimicrobial Chemotherapy |date=May 2010 |volume=65 |issue=8 |pages=1779–1783 |doi=10.1093/jac/dkq179 |pmid=20507860 |author=Goldberg, E; Paul, M; Talker, O; Samra, Z; Raskin, M; Hazzan, R; Leibovici, L; Bishara, J |url=http://jac.oxfordjournals.org/content/65/8/1779.full.pdf |format=PDF }}</ref><ref>{{cite journal |title=Dose of Trimethoprim-Sulfamethoxazole To Treat Skin and Skin Structure Infections Caused by Methicillin-Resistant ''Staphylococcus aureus'' |journal=Antimicrobial Agents and Chemotherapy |date=December 2011 |volume=55 |issue=12 |pages=5430–5432 |doi=10.1128/AAC.00706-11 |pmid=21930870 |pmc=3232808 |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232808/pdf/zac5430.pdf |format=PDF |author=Cadena, J; Nair, S; Henao-Martinez, AF; Jorgensen, JH; Patterson, JE; Sreeramoju, PV}}</ref><ref>{{cite journal |title=Daptomycin-Nonsusceptible Vancomycin-Intermediate ''Staphylococcus aureus'' Vertebral Osteomyelitis Cases Complicated by Bacteremia Treated with High-Dose Daptomycin and Trimethoprim-Sulfamethoxazole |journal=Antimicrobial Agents and Chemotherapy |date=November 2012 |volume=56 |issue=11 |pages=5990–5993 |doi=10.1128/AAC.01046-12 |pmid=22869580 |pmc=3486608 |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486608/pdf/zac5990.pdf |format=PDF |author=Avery, LM; Steed, ME; Woodruff, AE; Hasan, M; Rybak, MJ}}</ref>
|-
| ال[[سل]] || {{No}} || {{No}} || {{No}} || <ref>{{cite journal |title=Tuberculosis and trimethoprim-sulfamethoxazole |journal=Antimicrobial agents and chemotherapy |date=November 2009 |volume=53 |issue=11 |pages=4789–4793 |doi=10.1128/AAC.01658-08 |pmid=19564358 |pmc=2772331 |author=Forgacs, P; Wengenack, NL; Hall, L; Zimmerman, SK; Silverman, ML; Roberts, GD |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772331/pdf/1658-08.pdf |format=PDF }}</ref><ref>{{cite journal |title=The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in ''Mycobacterium tuberculosis'' |journal=Antimicrobial Agents and Chemotherapy |volume=56 |issue=10 |date=October 2012 |pages=5142–5148 |doi=10.1128/AAC.00832-12 |pmid=22825115 |author=Vilchèze, C; Jacobs, WR Jr |pmc=3457372 |url=http://www.ncbi.nlm.nih.gov.elibrary.jcu.edu.au/pmc/articles/PMC3457372/pdf/zac5142.pdf |format=PDF }}</ref><ref>{{cite journal |title=Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis |journal=The European Respiratory Journal |date=August 2013 |volume=42 |issue=2 |pages=504–512 |doi=10.1183/09031936.00114812 |pmid=23100498 |author=Alsaad, N; van Altena, R; Pranger, AD; van Soolingen, D; de Lange, WC; van der Werf, TS; Kosterink, JG; Alffenaar, JW}}</ref>
|-
| [[داء ويبل]] || {{No}} || {{No}} || {{No}} || <ref>{{cite journal |title=Whipple's Disease |journal=Clinical and Vaccine Immunology |volume=8 |issue=1 |pages=1–8 |doi=10.1128/CDLI.8.1.1-8.2001 |date=January 2001 |author=Fenollar, F; Raoult, D |url=http://cvi.asm.org/content/8/1/1.full.pdf |format=PDF }}</ref><ref>{{cite journal |title=Whipple's disease in Spain: a clinical review of 91 patients diagnosed between 1947 and 2001 |journal=Rev Esp Enferm Dig. |volume=102 |issue=2 |pages=108–123 |pmid=20361847 |author=Ojeda, E; Cosme, A; Lapaza, J; Torrado, J; Arruabarrena, I; Alzate, L |date=February 2010 |doi=10.4321/s1130-01082010000200006}}</ref><ref>{{cite journal |title=Whipple’s disease |journal=Postgraduate Medical Journal |date=November 2013 |volume=89 |issue=1057 |pages=659–665 |doi=10.1136/postgradmedj-2012-202684rep |pmid=24129033 |author=Puéchal, X |url=http://pmj.bmj.com.elibrary.jcu.edu.au/content/89/1057/659.full.pdf |format=PDF }}</ref>
|-
| colspan="5" align="center" | '''<big>عدوى الفطريات والأوليات</big>'''
| [[داء متماثلات البوائغ]] || {{No}} || {{No}} || {{No}} || <ref name="pmid18257775">{{cite journal |author=Lagrange-Xélot, M; Porcher, R; Sarfati, C; de Castro, N; Carel, O; Magnier, JD; Delcey, V; Molina, JM |title=Isosporiasis in patients with HIV infection in the highly active antiretroviral therapy era in France |journal=HIV Medicine |volume=9 |issue=2 |pages=126–30 |date=February 2008 |pmid=18257775 |doi=10.1111/j.1468-1293.2007.00530.x |url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1464-2662&date=2008&volume=9&issue=2&spage=126}}</ref>
|-
| [[ملاريا]] || {{No}} || {{No}} || {{No}} || <ref>{{cite journal |title=Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of ''Plasmodium falciparum'' Malaria: A Systematic Review |journal=PLoS ONE| year=2013 |volume=8 |issue=2 |pages=e56916 |doi=10.1371/journal.pone.0056916 |pmid=23451110 |pmc=3579948 |author=Manyando, C; Njunju, EM; D'Alessandro, U; Van Geertruyden, JP |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579948/pdf/pone.0056916.pdf |format=PDF }}</ref>
|-
| [[الالتهاب الرئوي بالمتكيسة الجؤجؤية]] || {{Yes}} || {{Yes}} || {{Yes}} || <ref>{{cite journal |title=Twice weekly ''Pneumocystis jiroveci'' pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia |journal=Journal of Pediatric Hematology/Oncology |date=January 2011 |volume=33 |issue=1 |pages=e1-4 |doi=10.1097/MPH.0b013e3181fd6fca |author=Agrawal, AK; Chang, PP; Feusner, J |pmid=21102354}}</ref> <ref>{{cite journal |title=Comparison of three regimens for treatment of mild to moderate ''Pneumocystis carinii'' pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. |journal=Annals of Internal Medicine |date=May 1996 |volume=124 |issue=9 |pages=792–802 |doi=10.7326/0003-4819-124-9-199605010-00003 |pmid=8610948 |author=Safrin, S; Finkelstein, DM; Feinberg, J; Frame, P; Simpson, G; Wu, A; Cheung, T; Soeiro, R; Hojczyk, P; Black, JR}}</ref>
|-
| [[داء المقوسات]] || {{Yes}} || {{Yes|<small>للوقاية فقط</small>}} || {{Yes}} || <ref>{{cite journal |title=Cotrimoxazole therapy of ''Toxoplasma gondii'' encephalitis in AIDS patients |date=February 1992 |volume=11 |issue=2 |pages=125–130 |doi=10.1007/BF01967063 |pmid=1396726 |author=Canessa, A; Del Bono, V; De Leo, P; Piersantelli, N; Terragna, A |journal=European Journal of Clinical Microbiology and Infectious Diseases}}</ref><ref>{{cite journal |title=Randomized Trial of Trimethoprim-Sulfamethoxazole versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic Encephalitis in Patients with AIDS |journal=Antimicrobial Agents and Chemotherapy |date=June 1998 |pmid=9624473 |pmc=105601 |volume=42 |issue=6 |pages=1346–1349 |author=Torre, D; Casari, S; Speranza, F; Donisi, A; Gregis, G; Poggio, A; Ranieri, S; Orani, A; Angarano, G; Chiodo, F; Fiori, G; Carosi, G |url=http://aac.asm.org/content/42/6/1346.full.pdf |format=PDF }}</ref><ref>{{cite journal |title=Trimethoprim-Sulfamethoxazole as Toxoplasmosis Prophylaxis for Heart Transplant Recipients |journal=Clinical Infectious Diseases |date=April 2003 |author=Muñoz, P; Arencibia, J; Rodríguez, C; Rivera, M; Palomo, J; Yañez, J; Bouza, E |volume=36 |issue=7 |pages=932–933 |doi=10.1086/368209 |pmid=12652396 |url=http://cid.oxfordjournals.org/content/36/7/932.full.pdf |format=PDF }}</ref><ref>{{cite journal |title=Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006 |journal=The American Journal of Tropical Medicine and Hygiene |date=April 2009 |volume=80 |issue=4 |pages=583–587 |pmid=19346380 |author=Béraud, G; Pierre-François, S; Foltzer, A; Abel, S; Liautaud, B; Smadja, D; Cabié, A |url=http://www.ajtmh.org/content/80/4/583.full.pdf |format=PDF }}</ref><ref>{{cite journal |title=Treatment of toxoplasmic lymphadenitis with co-trimoxazole: double-blind, randomized clinical trial |journal=International Journal of Infectious Diseases |date=September 2010 |volume=14 |issue=Supplement 3 |pages=e67-e69 |doi=10.1016/j.ijid.2009.11.015 |pmid=20194044 |url=http://www.sciencedirect.com/science/article/pii/S1201971210010970/pdfft?md5=ea140c83a389bd404c6b611577981b59&pid=1-s2.0-S1201971210010970-main.pdf |format=PDF |author=Alavi, SM; Alavi, L}}</ref><ref>{{cite journal |title=Successful treatment of cerebral toxoplasmosis with cotrimoxazole |journal=Indian Journal of Sexually Transmitted Diseases |date=January 2011 |volume=32 |issue=1 |pages=44–46 |doi=10.4103/0253-7184.81255 |pmid=21799577 |pmc=3139289 |author=Patil, HV; Patil, VC; Rajmane, V; Raje, V |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139289/?report=classic}}</ref>
|-
| colspan="5" align="center" | '''<big>استخدامات أخرى</big>'''
|-
| [[ورام حبيبي ويغنري]] || {{No}} || {{No}} || {{No}} ||<ref>{{cite journal |title=Treatment of Wegener's granulomatosis with sulfamethoxazole-trimethoprim |journal=Archives of Internal Medicine |date=August 1991 |volume=151 |issue=8 |pages=1649–1652 |doi=10.1001/archinte.1991.00400080133026 |pmid=1872670 |author=Valeriano-Marcet, J; Spiera, H}}</ref><ref>{{cite journal |title=Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group |journal=[[New England Journal of Medicine]] |volume=335 |issue=1 |pages=16–20 |doi=10.1056/NEJM199607043350103 |format=PDF |url=http://www.nejm.org/doi/pdf/10.1056/NEJM199607043350103 |author=Stegeman, CA; Tervaert, JW; de Jong, PE; Kallenberg, CG |date=July 1996 }}</ref>
|}
 
{{شريط بوابات|صيدلة|طب|الكيمياء}}
 
{{كوليرا}}
[[تصنيف:أدوية أساسية حسب منظمة الصحة العالمية]]
[[تصنيف:مضادات حيوية مركبة]]
1٬890٬551

تعديل